B. Riley Securities Initiates Coverage of Neuronetics at Buy
Fintel reports that on September 11, 2026, B. Riley Securities initiated coverage of Neuronetics (NASDAQGM:STIM) with a Buy recommendation.
Neuronetics, Inc., based in the United States, operates primarily within the medical device industry, focusing on pioneering treatments for psychiatric disorders. A notable project of Neuronetics is the development of its proprietary NeuroStar Advanced Therapy system, a non-invasive treatment that utilizes transcranial magnetic stimulation (TMS) technology to alleviate depression. The company's stock closed at $3.01 on September 10, 2026, which was also the pre-action close. This latest close follows a one-week price change of +10.66% from a baseline close of $2.72 on September 3, 2026, and a one-month price change of +38.71% from a baseline close of $2.17 on August 10, 2026.
The company reported its latest earnings on August 11, 2026. Neuronetics posted an actual EPS of -0.04, compared to the estimated EPS of -0.125. Actual revenue for the period was $41,568,000,000,000.00, exceeding the estimated revenue of $40,978,500,000,000.00. Prior to the rating action, as of August 28, 2026, the current consensus target mean and median for the stock was $6.12, representing an implied change of +103.32%. This consensus target reflects a revision of +33.33% from the prior consensus target mean of $4.59 recorded on August 4, 2026.
In the recommendation period of September 1, 2026, the aggregate analyst sentiment showed a total of 9 recommendations, consisting of 3 strong buy, 5 buy, 1 hold, 0 sell, and 0 strong sell ratings. This resulted in a positive recommendation percentage of 88.9% and a hold percentage of 11.1%. In the prior period of August 1, 2026, there were 10 total recommendations, including 3 strong buy, 6 buy, 1 hold, 0 sell, and 0 strong sell ratings, which represented a positive percentage of 90.0% and a hold percentage of 10.0%. Additionally, on September 9, 2026, BTIG reiterated its Buy rating on the stock.
Recent analyst actions
| Date | Analyst | Prior | Latest recommendation | Action |
|---|---|---|---|---|
| September 11, 2026 | B. Riley Securities | Buy | initiated coverage | |
| September 9, 2026 | BTIG | Buy | Buy | reiterated |
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.